These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 419044)
1. A new alpha and beta receptor antagonist in general practice. Manderson WS Practitioner; 1979 Jan; 222(1327):131-4. PubMed ID: 419044 [No Abstract] [Full Text] [Related]
2. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension]. Cybulska I; Sznajderman M; Brym E; Czerniewska E Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638 [No Abstract] [Full Text] [Related]
3. Labetalol for hypertension. Med Lett Drugs Ther; 1984 Sep; 26(670):83-5. PubMed ID: 6147747 [No Abstract] [Full Text] [Related]
4. Hypertension in general practice: a comparative study of labetalol and metoprolol (+/- prazosin) in general practice. Piterman L Aust Fam Physician; 1981 Jul; 10(7):579-83. PubMed ID: 7283872 [No Abstract] [Full Text] [Related]
10. Labetalol for hypertension. Drug Ther Bull; 1978 Nov; 16(23):89-90. PubMed ID: 699758 [No Abstract] [Full Text] [Related]
11. A clinical trial in general practice. Part 1: Report and comments. Gill D; Ward A; Bridges-Webb C Aust Fam Physician; 1984 Jul; 13(7):522-3. PubMed ID: 6487172 [TBL] [Abstract][Full Text] [Related]
12. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans. Vas A; Gachályi B; Káldor A Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757 [No Abstract] [Full Text] [Related]
13. [Acute hemodynamic effect of labetalol in severe hypertension]. Omvik P; Lund-Johansen P Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1971-4. PubMed ID: 7456057 [No Abstract] [Full Text] [Related]
14. [Ergometric control in hypertension treatment with labetalol]. Prohaska H; Honetz N Wien Med Wochenschr Suppl; 1981; 69():20-2. PubMed ID: 6952661 [No Abstract] [Full Text] [Related]
15. [Labetalol in ambulatory therapy of hypertension]. Zilcher H; Weber H; Glogar D Wien Med Wochenschr Suppl; 1981; 69():23-4. PubMed ID: 6952656 [No Abstract] [Full Text] [Related]
16. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group. N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511 [TBL] [Abstract][Full Text] [Related]
17. Effects of long-term high-dose labetalol on blood pressure in patients with severe hypertension resistant to previous therapy. Kristensen BO; la Cour Petersen E Postgrad Med J; 1980; 56 Suppl 2():57-9. PubMed ID: 7433344 [No Abstract] [Full Text] [Related]
18. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study]. Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868 [No Abstract] [Full Text] [Related]
19. Use of labetalol in the treatment of severe hypertension during pregnancy. Michael CA Br J Clin Pharmacol; 1979; 8(Suppl 2):211S-215S. PubMed ID: 526403 [TBL] [Abstract][Full Text] [Related]
20. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride]. Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048 [No Abstract] [Full Text] [Related] [Next] [New Search]